Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trialChristopher Adlbrecht, Jordi Rello, Pieter Depuydt et al.|Critical Care|2020Cited by 83